Javascript must be enabled to continue!
Semmelweis Ignác és az Orvosi Hetilap
View through CrossRef
Abstract: Ignác Semmelweis did not publish his discovery in Vienna – i.e., that the puerperal fever may be prevented by careful washing of the hand in chlorine solution (asepsis) – for ten years. The Medical Weekly started its publications edited by Lajos Markusovszky in Pest in 1857. Semmelweis as a professor of theoretical and practical obstetrics at the University of Pest published a study about puerperal fever in the first volume, and Hungarian physicians became familiar with Semmelweis’ opinion from this medical journal. Semmelweis was not only an author of the Medical Weekly, but he also edited a supplement of the Medical Weekly entitled Gynaecology and Paediatry. The Medical Weekly published regular accounts of the work of the clinic written by lecturers of Semmelweis and articles describing the most interesting cases of the clinic. Orv Hetil. 2018; 159(26): 1065–1070.
Title: Semmelweis Ignác és az Orvosi Hetilap
Description:
Abstract: Ignác Semmelweis did not publish his discovery in Vienna – i.
e.
, that the puerperal fever may be prevented by careful washing of the hand in chlorine solution (asepsis) – for ten years.
The Medical Weekly started its publications edited by Lajos Markusovszky in Pest in 1857.
Semmelweis as a professor of theoretical and practical obstetrics at the University of Pest published a study about puerperal fever in the first volume, and Hungarian physicians became familiar with Semmelweis’ opinion from this medical journal.
Semmelweis was not only an author of the Medical Weekly, but he also edited a supplement of the Medical Weekly entitled Gynaecology and Paediatry.
The Medical Weekly published regular accounts of the work of the clinic written by lecturers of Semmelweis and articles describing the most interesting cases of the clinic.
Orv Hetil.
2018; 159(26): 1065–1070.
Related Results
Az Orvosi Hetilap idézetelemzése mutatószámok alapján 2012 és 2016 között
Az Orvosi Hetilap idézetelemzése mutatószámok alapján 2012 és 2016 között
Abstract: Introduction: After getting indexed by scientific databases – Web of Science, Journal Citation Reports – the obtained scientific performance of the journal needs to be k...
Ignaz Semmelweis: a victim of harassment?
Ignaz Semmelweis: a victim of harassment?
SummaryIgnaz Semmelweis’ (1818–1865) discovery of the endemic causes offebris puerperalisis a striking example of the role of pathology in medicine. Transdisciplinarity encounters ...
Past and future of an IMI-PharmaTrain (IMI-PhT)-initiated multinational pharmaceutical medicine course at the Semmelweis University in Hungary
Past and future of an IMI-PharmaTrain (IMI-PhT)-initiated multinational pharmaceutical medicine course at the Semmelweis University in Hungary
The pharmaceutical medicine course at the Semmelweis University of Budapest, Hungary, was initiated as part of the Innovative Medicines Initiative (IMI is the main program, IMI-Pha...
A morte está em nossas mãos
A morte está em nossas mãos
Introdução: Com a alma e a consciência inflamadas pela revolta – após ler a saga de Semmelweis em tentar convencer seus contemporâneos sobre a importância da higienização das mãos ...
TheOrvosi Hetilap (Hungarian Medical Journal)in the network of medical journals
TheOrvosi Hetilap (Hungarian Medical Journal)in the network of medical journals
The role of networks is swiftly increasing in the production and communication of scientific knowledge. Network aspects have, therefore, an ever growing importance in the analysis ...
The medical relations of open access initiative
The medical relations of open access initiative
A sikeres orvosi munka és az orvostudományi kutatások fejlődésének egyik alapfeltétele a tudományos szakirodalmi források használata. Célunk az, hogy röviden bemutassuk az orvosi t...
Orvosi korpuszok és történetiség
Orvosi korpuszok és történetiség
A tanulmány középpontjában az orvosi nyelvi korpuszok témaköre áll. Az írás bemutatja a modern kori orvosi szaknyelvhez kötődő adatbázisok néhány tendenciáját, majd ismerteti a Cor...
A TNFα-gátló szemészeti alkalmazása: adalimumabkezelés uveitisben
A TNFα-gátló szemészeti alkalmazása: adalimumabkezelés uveitisben
Összefoglaló.
Bevezetés: Az adalimumab egy TNFα-gátló monoklonális antitest;
számos indikációja közül a nem fertőzéses eredetű intermedier, ...

